Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS, Sidman RL, Morgan JI, Zuo J (2002). "Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1". Science. 295 (5561): 1904–6. Bibcode:2002Sci...295.1904F. doi:10.1126/science.1068912. PMID11884758. S2CID24520602.
Harris A, Morgan JI, Pecot M, Soumare A, Osborne A, Soares HD (2000). "Regenerating motor neurons express Nna1, a novel ATP/GTP-binding protein related to zinc carboxypeptidases". Mol Cell Neurosci. 16 (5): 578–96. doi:10.1006/mcne.2000.0900. PMID11083920. S2CID32298322.
Chakrabarti L, Neal JT, Miles M, Martinez RA, Smith AC, Sopher BL, La Spada AR (2006). "The Purkinje cell degeneration 5J mutation is a single amino acid insertion that destabilizes Nna1 protein". Mamm Genome. 17 (2): 103–110. doi:10.1007/s00335-005-0096-x. PMID16465590. S2CID19289988.
McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID2896308. S2CID20566736.
Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID455087. S2CID19618884.
Wassef M, Simons J, Tappaz ML, Sotelo C (1986). "Non-Purkinje cell GABAergic innervation of the deep cerebellar nuclei: a quantitative immunocytochemical study in C57BL and in Purkinje cell degeneration mutant mice". Brain Res. 399 (1): 125–135. doi:10.1016/0006-8993(86)90606-2. PMID3542126. S2CID12720868.
Stasi K, Mitsacos A, Triarhou LC, Kouvelas ED (1997). "Cerebellar grafts partially reverse amino acid receptor changes observed in the cerebellum of mice with hereditary ataxia: quantitative autoradiographic studies". Cell Transplant. 6 (3): 347–59. doi:10.1016/s0963-6897(97)00036-5. PMID9171167.
Garin N, Hornung JP, Escher G (2002). "Distribution of postsynaptic GABA(A) receptor aggregates in the deep cerebellar nuclei of normal and mutant mice". J Comp Neurol. 447 (3): 210–7. doi:10.1002/cne.10226. PMID11984816. S2CID24088948.
McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID2896308. S2CID20566736.
Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID455087. S2CID19618884.
Fragioudaki K, Giompres P, Smith AL, Triarhou LC, Kouvelas ED, Mitsacos A (2002). "AMPA receptor subunit RNA transcripts and [(3)H]AMPA binding in the cerebellum of normal and pcd mutant mice: an in situ hybridization study combined with receptor autoradiography". J Neural Transm. 109 (9): 1115–27. doi:10.1007/s00702-001-0682-3. PMID12203039. S2CID22557348.
Ohsugi K, Adachi K, Ando K (1986). "Serotonin metabolism in the CNS in cerebellar ataxic mice". Experientia. 42 (11–12): 1245–7. doi:10.1007/BF01946406. PMID2430828. S2CID1510598.
Triarhou LC, Ghetti B (1991). "Serotonin-immunoreactivity in the cerebellum of two neurological mutant mice and the corresponding wild-type genetic stocks". J Chem Neuroanat. 4 (6): 421–8. doi:10.1016/0891-0618(91)90022-5. PMID1781951. S2CID13729250.
Le Marec N, Hébert C, Amdiss F, Botez MI, Reader TA (1998). "Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [3H]citalopram". J Chem Neuroanat. 15 (3): 155–71. doi:10.1016/s0891-0618(98)00041-6. PMID9797073. S2CID21369858.
Ghetti B, Perry KW, Fuller RW (1988). "Serotonin concentration and turnover in cerebellum and other brain regions of pcd mutant mice". Brain Res. 458 (2): 367–71. doi:10.1016/0006-8993(88)90480-5. PMID2463052. S2CID36772221.
Kostrzewa RM, Harston CT (1986). "Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration". Neuroscience. 18 (4): 809–15. doi:10.1016/0306-4522(86)90101-6. PMID3762927. S2CID45209526.
Ghetti B, Perry KW, Fuller RW (1987). "Norepinephrine metabolism in the cerebellum of the Purkinje cell degeneration (pcd) mutant mouse". Neurochem. Int. 10 (1): 39–47. doi:10.1016/0197-0186(87)90170-7. PMID20501080. S2CID19294786.
Roffler-Tarlov S, Landis SC, Zigmond MJ (1984). "Effects of Purkinje cell degeneration on the noradrenergic projection to mouse cerebellar cortex". Brain Res. 298 (2): 303–11. doi:10.1016/0006-8993(84)91429-x. PMID6144362. S2CID43603541.
Felten, DL, Felten, SY, Perry, KW, Fuller RW, Nurnberger JI, Ghetti B (1986). "Noradrenergic innervation of the cerebellar cortex in normal and in Purkinje cell degeneration mutant mice: evidence for long term survival following loss of the two major cerebellar cortical neuronal populations". Neuroscience. 18 (4): 783–93. doi:10.1016/0306-4522(86)90099-0. PMID3762925. S2CID21903927.
Strazielle C, Lalonde R, Hébert N, Reader TA (1999). "Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study". Neuroscience. 80 (3): 343–6. doi:10.1016/s0306-4522(99)00321-8. PMID10613519. S2CID140206348.
Delis F, Mitsacos A, Giompres P (2004). "Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice". Neuroscience. 125 (1): 255–68. doi:10.1016/j.neuroscience.2004.01.020. PMID15051164. S2CID26876977.
Wang T, Parris J, Li L, Morgan JI (2006). "The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype". Mol Cell Neurosci. 33 (2): 200–13. doi:10.1016/j.mcn.2006.07.009. PMID16952463. S2CID20220682.
Le Marec N, Lalonde R (1997). "Sensorimotor learning and retention during equilibrium tests in Purkinje cell degeneration mutant mice". Brain Res. 768 (1–2): 310–16. doi:10.1016/s0006-8993(97)00666-5. PMID9369330. S2CID7015807.
Le Marec N, Lalonde R (1998). "Treadmill performance of mice with cerebellar lesions: 1. Purkinje cell degeneration mutant mice". Behav Neurosci. 112 (1): 225–232. doi:10.1037/0735-7044.112.1.225. PMID9517830.
Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS, Sidman RL, Morgan JI, Zuo J (2002). "Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1". Science. 295 (5561): 1904–6. Bibcode:2002Sci...295.1904F. doi:10.1126/science.1068912. PMID11884758. S2CID24520602.
Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS, Sidman RL, Morgan JI, Zuo J (2002). "Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1". Science. 295 (5561): 1904–6. Bibcode:2002Sci...295.1904F. doi:10.1126/science.1068912. PMID11884758. S2CID24520602.
Harris A, Morgan JI, Pecot M, Soumare A, Osborne A, Soares HD (2000). "Regenerating motor neurons express Nna1, a novel ATP/GTP-binding protein related to zinc carboxypeptidases". Mol Cell Neurosci. 16 (5): 578–96. doi:10.1006/mcne.2000.0900. PMID11083920. S2CID32298322.
Chakrabarti L, Neal JT, Miles M, Martinez RA, Smith AC, Sopher BL, La Spada AR (2006). "The Purkinje cell degeneration 5J mutation is a single amino acid insertion that destabilizes Nna1 protein". Mamm Genome. 17 (2): 103–110. doi:10.1007/s00335-005-0096-x. PMID16465590. S2CID19289988.
McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID2896308. S2CID20566736.
Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID455087. S2CID19618884.
Wassef M, Simons J, Tappaz ML, Sotelo C (1986). "Non-Purkinje cell GABAergic innervation of the deep cerebellar nuclei: a quantitative immunocytochemical study in C57BL and in Purkinje cell degeneration mutant mice". Brain Res. 399 (1): 125–135. doi:10.1016/0006-8993(86)90606-2. PMID3542126. S2CID12720868.
Stasi K, Mitsacos A, Triarhou LC, Kouvelas ED (1997). "Cerebellar grafts partially reverse amino acid receptor changes observed in the cerebellum of mice with hereditary ataxia: quantitative autoradiographic studies". Cell Transplant. 6 (3): 347–59. doi:10.1016/s0963-6897(97)00036-5. PMID9171167.
Garin N, Hornung JP, Escher G (2002). "Distribution of postsynaptic GABA(A) receptor aggregates in the deep cerebellar nuclei of normal and mutant mice". J Comp Neurol. 447 (3): 210–7. doi:10.1002/cne.10226. PMID11984816. S2CID24088948.
McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID2896308. S2CID20566736.
Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID455087. S2CID19618884.
Fragioudaki K, Giompres P, Smith AL, Triarhou LC, Kouvelas ED, Mitsacos A (2002). "AMPA receptor subunit RNA transcripts and [(3)H]AMPA binding in the cerebellum of normal and pcd mutant mice: an in situ hybridization study combined with receptor autoradiography". J Neural Transm. 109 (9): 1115–27. doi:10.1007/s00702-001-0682-3. PMID12203039. S2CID22557348.
Ohsugi K, Adachi K, Ando K (1986). "Serotonin metabolism in the CNS in cerebellar ataxic mice". Experientia. 42 (11–12): 1245–7. doi:10.1007/BF01946406. PMID2430828. S2CID1510598.
Triarhou LC, Ghetti B (1991). "Serotonin-immunoreactivity in the cerebellum of two neurological mutant mice and the corresponding wild-type genetic stocks". J Chem Neuroanat. 4 (6): 421–8. doi:10.1016/0891-0618(91)90022-5. PMID1781951. S2CID13729250.
Le Marec N, Hébert C, Amdiss F, Botez MI, Reader TA (1998). "Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [3H]citalopram". J Chem Neuroanat. 15 (3): 155–71. doi:10.1016/s0891-0618(98)00041-6. PMID9797073. S2CID21369858.
Ghetti B, Perry KW, Fuller RW (1988). "Serotonin concentration and turnover in cerebellum and other brain regions of pcd mutant mice". Brain Res. 458 (2): 367–71. doi:10.1016/0006-8993(88)90480-5. PMID2463052. S2CID36772221.
Kostrzewa RM, Harston CT (1986). "Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration". Neuroscience. 18 (4): 809–15. doi:10.1016/0306-4522(86)90101-6. PMID3762927. S2CID45209526.
Ghetti B, Perry KW, Fuller RW (1987). "Norepinephrine metabolism in the cerebellum of the Purkinje cell degeneration (pcd) mutant mouse". Neurochem. Int. 10 (1): 39–47. doi:10.1016/0197-0186(87)90170-7. PMID20501080. S2CID19294786.
Roffler-Tarlov S, Landis SC, Zigmond MJ (1984). "Effects of Purkinje cell degeneration on the noradrenergic projection to mouse cerebellar cortex". Brain Res. 298 (2): 303–11. doi:10.1016/0006-8993(84)91429-x. PMID6144362. S2CID43603541.
Felten, DL, Felten, SY, Perry, KW, Fuller RW, Nurnberger JI, Ghetti B (1986). "Noradrenergic innervation of the cerebellar cortex in normal and in Purkinje cell degeneration mutant mice: evidence for long term survival following loss of the two major cerebellar cortical neuronal populations". Neuroscience. 18 (4): 783–93. doi:10.1016/0306-4522(86)90099-0. PMID3762925. S2CID21903927.
Strazielle C, Lalonde R, Hébert N, Reader TA (1999). "Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study". Neuroscience. 80 (3): 343–6. doi:10.1016/s0306-4522(99)00321-8. PMID10613519. S2CID140206348.
Delis F, Mitsacos A, Giompres P (2004). "Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice". Neuroscience. 125 (1): 255–68. doi:10.1016/j.neuroscience.2004.01.020. PMID15051164. S2CID26876977.
Wang T, Parris J, Li L, Morgan JI (2006). "The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype". Mol Cell Neurosci. 33 (2): 200–13. doi:10.1016/j.mcn.2006.07.009. PMID16952463. S2CID20220682.
Le Marec N, Lalonde R (1997). "Sensorimotor learning and retention during equilibrium tests in Purkinje cell degeneration mutant mice". Brain Res. 768 (1–2): 310–16. doi:10.1016/s0006-8993(97)00666-5. PMID9369330. S2CID7015807.
Le Marec N, Lalonde R (1998). "Treadmill performance of mice with cerebellar lesions: 1. Purkinje cell degeneration mutant mice". Behav Neurosci. 112 (1): 225–232. doi:10.1037/0735-7044.112.1.225. PMID9517830.
Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS, Sidman RL, Morgan JI, Zuo J (2002). "Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1". Science. 295 (5561): 1904–6. Bibcode:2002Sci...295.1904F. doi:10.1126/science.1068912. PMID11884758. S2CID24520602.
Harris A, Morgan JI, Pecot M, Soumare A, Osborne A, Soares HD (2000). "Regenerating motor neurons express Nna1, a novel ATP/GTP-binding protein related to zinc carboxypeptidases". Mol Cell Neurosci. 16 (5): 578–96. doi:10.1006/mcne.2000.0900. PMID11083920. S2CID32298322.
Chakrabarti L, Neal JT, Miles M, Martinez RA, Smith AC, Sopher BL, La Spada AR (2006). "The Purkinje cell degeneration 5J mutation is a single amino acid insertion that destabilizes Nna1 protein". Mamm Genome. 17 (2): 103–110. doi:10.1007/s00335-005-0096-x. PMID16465590. S2CID19289988.
Ghetti B, Norton, J, Triarhou, LC (1987). "Nerve cell atrophy and loss in the inferior olivary complex of 'Purkinje cell degeneration' mutant mice". J Comp Neurol. 260 (3): 409–22. doi:10.1002/cne.902600307. PMID3597839. S2CID37783783.
Triarhou LC, Norton J, Ghetti B (1987). "Anterograde transsynaptic degeneration in the deep cerebellar nuclei of Purkinje cell degeneration (pcd) mutant mice". Exp Brain Res. 66 (3): 577–88. doi:10.1007/BF00270691. PMID3609202. S2CID2596179.
McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID2896308. S2CID20566736.
Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID455087. S2CID19618884.
Wassef M, Simons J, Tappaz ML, Sotelo C (1986). "Non-Purkinje cell GABAergic innervation of the deep cerebellar nuclei: a quantitative immunocytochemical study in C57BL and in Purkinje cell degeneration mutant mice". Brain Res. 399 (1): 125–135. doi:10.1016/0006-8993(86)90606-2. PMID3542126. S2CID12720868.
Garin N, Hornung JP, Escher G (2002). "Distribution of postsynaptic GABA(A) receptor aggregates in the deep cerebellar nuclei of normal and mutant mice". J Comp Neurol. 447 (3): 210–7. doi:10.1002/cne.10226. PMID11984816. S2CID24088948.
McBride WJ, Ghetti B (1988). "Changes in the content of glutamate and GABA in the cerebellar vermis and hemispheres of the Purkinje cell degeneration (pcd) mutant". Neurochem Res. 13 (2): 121–5. doi:10.1007/BF00973323. PMID2896308. S2CID20566736.
Roffler-Tarlov S, Beart PM, O'Gorman S, Sidman RL (1979). "Neurochemical and morphological consequences of axon terminal degeneration in cerebellar deep nuclei of mice with inherited Purkinje cell degeneration". Brain Res. 168 (1): 75–95. doi:10.1016/0006-8993(79)90129-x. PMID455087. S2CID19618884.
Fragioudaki K, Giompres P, Smith AL, Triarhou LC, Kouvelas ED, Mitsacos A (2002). "AMPA receptor subunit RNA transcripts and [(3)H]AMPA binding in the cerebellum of normal and pcd mutant mice: an in situ hybridization study combined with receptor autoradiography". J Neural Transm. 109 (9): 1115–27. doi:10.1007/s00702-001-0682-3. PMID12203039. S2CID22557348.
Ohsugi K, Adachi K, Ando K (1986). "Serotonin metabolism in the CNS in cerebellar ataxic mice". Experientia. 42 (11–12): 1245–7. doi:10.1007/BF01946406. PMID2430828. S2CID1510598.
Triarhou LC, Ghetti B (1991). "Serotonin-immunoreactivity in the cerebellum of two neurological mutant mice and the corresponding wild-type genetic stocks". J Chem Neuroanat. 4 (6): 421–8. doi:10.1016/0891-0618(91)90022-5. PMID1781951. S2CID13729250.
Le Marec N, Hébert C, Amdiss F, Botez MI, Reader TA (1998). "Regional distribution of 5-HT transporters in the brain of wild type and 'Purkinje cell degeneration' mutant mice: a quantitative autoradiographic study with [3H]citalopram". J Chem Neuroanat. 15 (3): 155–71. doi:10.1016/s0891-0618(98)00041-6. PMID9797073. S2CID21369858.
Ghetti B, Perry KW, Fuller RW (1988). "Serotonin concentration and turnover in cerebellum and other brain regions of pcd mutant mice". Brain Res. 458 (2): 367–71. doi:10.1016/0006-8993(88)90480-5. PMID2463052. S2CID36772221.
Kostrzewa RM, Harston CT (1986). "Altered histofluorescent pattern of noradrenergic innervation of the cerebellum of the mutant mouse Purkinje cell degeneration". Neuroscience. 18 (4): 809–15. doi:10.1016/0306-4522(86)90101-6. PMID3762927. S2CID45209526.
Ghetti B, Perry KW, Fuller RW (1987). "Norepinephrine metabolism in the cerebellum of the Purkinje cell degeneration (pcd) mutant mouse". Neurochem. Int. 10 (1): 39–47. doi:10.1016/0197-0186(87)90170-7. PMID20501080. S2CID19294786.
Roffler-Tarlov S, Landis SC, Zigmond MJ (1984). "Effects of Purkinje cell degeneration on the noradrenergic projection to mouse cerebellar cortex". Brain Res. 298 (2): 303–11. doi:10.1016/0006-8993(84)91429-x. PMID6144362. S2CID43603541.
Felten, DL, Felten, SY, Perry, KW, Fuller RW, Nurnberger JI, Ghetti B (1986). "Noradrenergic innervation of the cerebellar cortex in normal and in Purkinje cell degeneration mutant mice: evidence for long term survival following loss of the two major cerebellar cortical neuronal populations". Neuroscience. 18 (4): 783–93. doi:10.1016/0306-4522(86)90099-0. PMID3762925. S2CID21903927.
Strazielle C, Lalonde R, Hébert N, Reader TA (1999). "Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study". Neuroscience. 80 (3): 343–6. doi:10.1016/s0306-4522(99)00321-8. PMID10613519. S2CID140206348.
Delis F, Mitsacos A, Giompres P (2004). "Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice". Neuroscience. 125 (1): 255–68. doi:10.1016/j.neuroscience.2004.01.020. PMID15051164. S2CID26876977.
Wang T, Parris J, Li L, Morgan JI (2006). "The carboxypeptidase-like substrate-binding site in Nna1 is essential for the rescue of the Purkinje cell degeneration (pcd) phenotype". Mol Cell Neurosci. 33 (2): 200–13. doi:10.1016/j.mcn.2006.07.009. PMID16952463. S2CID20220682.
Le Marec N, Lalonde R (1997). "Sensorimotor learning and retention during equilibrium tests in Purkinje cell degeneration mutant mice". Brain Res. 768 (1–2): 310–16. doi:10.1016/s0006-8993(97)00666-5. PMID9369330. S2CID7015807.